Filing Details
- Accession Number:
- 0000899243-21-011086
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-03-10 21:30:11
- Reporting Period:
- 2021-03-09
- Accepted Time:
- 2021-03-10 21:30:11
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1576263 | Mirati Therapeutics Inc. | MRTX | () | 1231 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1015747 | Joseph Lewis | Cay House, Ep Taylor Drive Lyford Cay New Providence C5 N7776 | No | No | Yes | No | |
1642355 | Ltd. Braslyn | Cay House, Ep Taylor Drive Lyford Cay, New Providence C5 N7776 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2021-03-09 | 1,107 | $195.82 | 3,134,859 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-03-09 | 4,633 | $197.30 | 3,130,226 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-03-09 | 3,993 | $197.81 | 3,126,233 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-03-09 | 2,237 | $199.08 | 3,123,996 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2021-03-09 | 11,971 | $0.00 | 3,135,967 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-03-09 | 1 | $191.00 | 3,135,966 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-03-10 | 189 | $195.52 | 3,135,777 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-03-10 | 20 | $196.12 | 3,135,757 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-03-10 | 200 | $198.00 | 3,135,557 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2021-03-10 | 410 | $0.00 | 3,135,967 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-03-10 | 1 | $195.90 | 3,135,966 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Warrant (right to purchase) | Disposition | 2020-03-09 | 11,971 | $5.60 | 11,971 | $0.00 |
Common Stock | Warrant (right to purchase) | Disposition | 2020-03-10 | 410 | $5.60 | 410 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
3,578,450 | 2017-01-06 | No | 4 | M | Direct | |
3,578,040 | 2017-01-06 | No | 4 | M | Direct |
Footnotes
- Tese securities are owned directly by Braslyn Ltd ("Braslyn"), which may be deemed to be a member of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn, (ii) Boxer Capital, LLC, (iii) Boxer Asset Management Inc., (iv) MVA Investors, LLC, (v) Lockend Five, LLC, (vi) Joe Lewis, (vii) Ivan M. Lieberburg, (viii) Aaron I. Davis, (ix) Shehan B. Dissanayake, and (x) Christopher Fuglesang (collectively, the "Boxer Group). Each of Messrs. Fuglesang, Lieberburg, Dissanayake and Davis is a member of Boxer Capital. Each member of the Boxer Group other than Braslyn disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein.
- Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $195.24 to $196.20.
- Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $196.55 to $197.53.
- Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $197.56 to $198.23.
- Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $198.62 to $199.46.
- Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $195.11 to $196.09.
- The warrants do not have an expiration date and are not exercisable to the extent that, following exercise of such warrants, the warrant holder and its affiliates would beneficially own more than 19.99% of the issuer's common stock.